Evidence map›Paper›PMID 31035514›Full record

ReviewNutrients2019

Low-Carb and Ketogenic Diets in Type 1 and Type 2 Diabetes.

Andrea Mario Bolla, Amelia Caretto, Andrea Laurenzi, Marina Scavini, Lorenzo Piemonti

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06273631 (Effect of Changes in Carbohydrate Intake Patterns on Glucose Control in Patients With Type 1 Diabetes), which is not on this map. Cited by 103 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 11 pooled it
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06273631 narecruitingnot on this mapstarted 2024, after this paper: background citation

Effect of Changes in Carbohydrate Intake Patterns on Glucose Control in Patients With Type 1 Diabetes

TypeinterventionalSponsorYang TaoRan2024 to 2027Enrolled80ConditionsType 1 Diabetes, Diet Intervention, Glucose ControlArmsdiverse carbohydrate diet, moderate carbohydrate diet
3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 11 syntheses or guidelines pooled it, 222 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Ketogenic diet, cardiometabolic diseases and aging.Journal of geriatric cardiology : JGC · 2026
    Article
  17. Review
  18. Review
  19. Review
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Andrea Mario BollaDiabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy. bolla.andreamario@hsr.it.
Amelia CarettoDiabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy. caretto.amelia@hsr.it.
Andrea LaurenziDiabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy. laurenzi.andrea@hsr.it.
Marina ScaviniDiabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy. scavini.marina@hsr.it.
Lorenzo PiemontiDiabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy. piemonti.lorenzo@hsr.it.
Vita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low-carb and ketogenic diets are popular among clinicians and patients, but the appropriateness of reducing carbohydrates intake in obese patients and in patients with diabetes is still debated. Studies in the literature are indeed controversial, possibly because these diets are generally poorly defined; this, together with the intrinsic complexity of dietary interventions, makes it difficult to compare results from different studies. Despite the evidence that reducing carbohydrates intake lowers body weight and, in patients with type 2 diabetes, improves glucose control, few data are available about sustainability, safety and efficacy in the long-term. In this review we explored the possible role of low-carb and ketogenic diets in the pathogenesis and management of type 2 diabetes and obesity. Furthermore, we also reviewed evidence of carbohydrates restriction in both pathogenesis of type 1 diabetes, through gut microbiota modification, and treatment of type 1 diabetes, addressing the legitimate concerns about the use of such diets in patients who are ketosis-prone and often have not completed their growth.

Indexed as

Diet, Carbohydrate-RestrictedDiet, KetogenicDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Humanscarbohydratesdiabetesdietary patternsketogenicnutritional intervention

Identifiers

PMID31035514
PMCPMC6566854
OpenAlexW2940972167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.